Pro Top & Mediking Company Limited
Quick facts
Marketed products
- Trabeculectomy with MMC · Ophthalmology
Trabeculectomy with MMC is a surgical procedure that creates a drainage pathway in the eye while using mitomycin C to prevent scar tissue formation and maintain long-term filtration.
Phase 3 pipeline
- MMC in glaucoma filtering surgery · Ophthalmology
MMC (mitomycin C) inhibits fibroblast proliferation and collagen synthesis to prevent scarring after glaucoma filtering surgery. - MMC in Trabeculectomy · Ophthalmology
Mitomycin C (MMC) is an alkylating agent that inhibits fibroblast proliferation and collagen synthesis to prevent scarring during trabeculectomy surgery.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Pro Top & Mediking Company Limited portfolio CI brief
- Pro Top & Mediking Company Limited pipeline updates RSS
Frequently asked questions about Pro Top & Mediking Company Limited
What are Pro Top & Mediking Company Limited's marketed drugs?
Top marketed products include Trabeculectomy with MMC.
What is Pro Top & Mediking Company Limited's pipeline?
Pro Top & Mediking Company Limited has 2 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include MMC in glaucoma filtering surgery, MMC in Trabeculectomy.
Related
- Trabeculectomy with MMC · Ophthalmology
- Sector hub: All tracked pharma companies